ロード中...
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance
OBJECTIVE: Plasma glycated CD59 (pGCD59) is an emerging biomarker in diabetes. We assessed whether pGCD59 could predict the following: the results of the glucose challenge test (GCT) for screening of gestational diabetes mellitus (GDM) (primary analysis); and the diagnosis of GDM and prevalence of l...
保存先:
| 出版年: | Diabetes Care |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Diabetes Association
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5481979/ https://ncbi.nlm.nih.gov/pubmed/28450368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc16-2598 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|